Fresenius SE KGaAXSWX:FRE 71 3-1 Month Momentum % is -17.88% as of Jul. 02, 2026. GuruFocus rates XSWX:FRE with a GF Score™ of 71/100 and a GF Value™ of CHF32.22 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 678 Healthcare Providers & Services companies, Fresenius SE KGaA ranks worse than 85.55% on this metric.
3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-07-02), Fresenius SE KGaA's 3-1 Month Momentum % is -17.88%.
The industry rank for Fresenius SE KGaA's 3-1 Month Momentum % or its related term are showing as below:
XSWX:FRE's 3-1 Month Momentum % is ranked worse than 85.55% of 678
companies
in the Healthcare Providers & Services industry
Industry Median: -2.095
vs XSWX:FRE: -17.88
Fresenius SE KGaA (XSWX:FRE) 3-1 Month Momentum % Explanation
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Fresenius SE KGaA 3-1 Month Momentum % Related Terms
XSWX:FRE vs HCA, THC, DVA: 3-1 Month Momentum % Comparison
For the Medical Care Facilities subindustry, Fresenius SE KGaA's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fresenius SE KGaA 3-1 Month Momentum % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Fresenius SE KGaA's 3-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Fresenius SE KGaA's 3-1 Month Momentum % falls into.
Fresenius SE KGaA (XSWX:FRE) 3-1 Month Momentum % Calculation
3-1 Month Momentum % is calculated as following:
3-1 Month Momentum %
=
( Price 1-month ago
/
Price 3-month ago
- 1 )
*
100 %
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fresenius SE KGaA (XSWX:FRE) has a 3-1 Month Momentum % of -17.88% as of Jul. 02, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Fresenius SE KGaA and its competitors. According to the industry distribution chart, Fresenius SE KGaA ranks #580 out of 678 companies in the Healthcare Providers & Services industry, placing it in the top 85.5%.
Is Fresenius SE KGaA's 3-1 Month Momentum % too high?
Fresenius SE KGaA's current 3-1 Month Momentum % is -17.88%. Based on the distribution chart, Fresenius SE KGaA ranks #580 out of 678 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Fresenius SE KGaA has a GF Score™ of 71/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Fresenius SE KGaA's 3-1 Month Momentum % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Fresenius SE KGaA ranks #580 out of 678 companies for 3-1 Month Momentum %. This places Fresenius SE KGaA in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for a Healthcare Providers & Services company?
A good 3-1 Month Momentum % depends on the Healthcare Providers & Services industry context. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Fresenius SE KGaA and its competitors. Fresenius SE KGaA's current 3-1 Month Momentum % is -17.88%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fresenius SE KGaA stock overvalued right now?
Based on GuruFocus' analysis, Fresenius SE KGaA (XSWX:FRE) is currently considered Modestly Overvalued. The stock's GF Value™ is CHF32.22, compared to a current price of CHF36.15 — trading 12.2% above its estimated fair value. The current 3-1 Month Momentum % is -17.88%. Fresenius SE KGaA's overall GF Score™ is 71/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For Fresenius SE KGaA (XSWX:FRE), the current 3-1 Month Momentum % is -17.88% as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fresenius SE KGaA (XSWX:FRE) Overvalued in 2026?
Based on GuruFocus' analysis, Fresenius SE KGaA stock appears to be overvalued.
The current stock price of CHF36.15 is trading 12.2% above its estimated GF Value™ of CHF32.22.
GuruFocus considers Fresenius SE KGaA to be Modestly Overvalued.
Key valuation signals for XSWX:FRE:
3-1 Month Momentum %: -17.88%
GF Value™: CHF32.22 vs. price of CHF36.15 (12.2% above fair value)
No single metric tells the full story. See the XSWX:FRE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fresenius is a healthcare holding company based in Germany. The company owns a minority stake in dialysis service provider and equipment manufacturer Fresenius Medical Care. The Kabi segment manufactures intravenous drugs, nutrition products, infusion and transfusion therapies, and related pumps. The Helios segment operates private hospitals primarily in Germany and Spain.
71GF Score
Get the complete analysis for XSWX:FRE
3-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:FRE has been successfully added to your 